Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma

Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma

Renal cell carcinoma (RCC) is a frequent urological malignancy characterized by a high rate of metastasis and lethality. The treatment strategy for advanced RCC has moved through multiple iterations over the past three decades. Initially, cytokine treatment was the only systemic treatment option for...

Full description

Bibliographic Details
Main Authors: Siwei Yang, Xianrui Yang, Zekai Hou, Liang Zhu, Zhili Yao, Yifei Zhang, Yanzhuo Chen, Jie Teng, Cheng Fang, Songmao Chen, Mingfei Jia, Zhifei Liu, Shaosan Kang, Yegang Chen, Gang Li, Yuanjie Niu, Qiliang Cai
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Heliyon
Subjects:
Renal cell carcinoma
Targeted therapy
Immune checkpoint inhibition
Combination therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024052460

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024052460

Similar Items